KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies

Ignace Vergote, Bente Lund, Z Ujmajuridze, H. Havsteen, T Rashal, J McCartney, M Kauffman, S Shacham, Mansoor Raza Mirza

Research output: Contribution to journalConference abstract in journalResearchpeer-review

1 Citation (Scopus)
Original languageEnglish
JournalInternational Journal of Gynecological Cancer
Volume29
Issue number9, 4 suppl.
Pages (from-to)1182
ISSN1048-891X
Publication statusPublished - 2014
EventBiennial Meeting of the International Gynecologic - Melbourne, Australia
Duration: 8 Nov 201411 Nov 2014
Conference number: 15th

Conference

ConferenceBiennial Meeting of the International Gynecologic
Number15th
CountryAustralia
CityMelbourne
Period08/11/201411/11/2014

Cite this